Endocrine Procedural Complications, Laryngeal Injury, Parathyroid; Deficiency, Thyroid
Conditions
Brief summary
The goal of this study is to evaluate the role of intraoperative continous and intermittent neuromonitoring and intraoperative parathormone (PTH) to predict postoperative nerve morbidity and hypocalcemia.
Detailed description
Intraoperative PTH values and intraoperative continuous neuromonitoring will be collected prospectively in consecutive patients who undergo total thyroidectomy. Postoperative parathyroid morbidity and recurrent laryngeal nerve morbidity will be evaluated within 1 week after total thyroidectomy and at 1 year postoperatively. Other postoperative morbidity will be evaluated at 1 year postoperatively using validated classification.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* patients scheduled for total thyroidectomy in university of Nancy (University Hospital)
Exclusion criteria
* refusal to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| intraoperative parathormone values | intraoperative | parathormone in pg/mL |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| postoperative hypoparathyroidism | within 1 week after thyroidectomy | parathormone in pg/mL |
| permanent postoperative hypocalcemia | at one year after thyroidectomy | calcium in mg/L |
| postoperative hypocalcemia | within 1 week after thyroidectomy | calcium in mg/L |
| laryngeal nerve palsy | during thyroidectomy | continuous intraoperative neuromonitoring (\> 50% baseline values yes/no) |
| Postoperative complications other than outcomes from 1 to 8 | at one year after thyroidectomy | Postoperative morbidity classification (using a Clavien-Dindo classification) postoperatively |
| permanent postoperative hypoparathyroidism | at one year after thyroidectomy | parathormone in pg/mL |
Countries
France